Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Depressed woman with head in hands

UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...

Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic...

It would be hard to find an area of health where the microbiome has not been implicated as a major player. The microbiome is...
Coronavirus

Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration

The companies will partner on a proof-of-concept project focused on detection of SARS-CoV-2 coronavirus as the first initiative of a broader collaboration focused on developing molecular diagnostic tests for infectious diseases and oncology.
coronavirus,3d render

Genetic Study Shows Coronavirus Evolved Naturally, Is not Lab-Constructed

Scripps researchers compare available genome sequence data for known coronavirus strains to determine that that SARS-CoV-2 originated through natural processes and note that their results “clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.”

Small Sequencer Developer GenapSys Completes $90M Series C Financing

GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
Portrait Of Senior Man Lying Down On Bed At Hospital

Risk Factors for Inpatient Death from Coronavirus Identified

A study of 191 patients—137 survivors and 54 non-survivors—from two hospitals in Wuhan, China showed key risk factors for death were advanced age, signs of sepsis, and blood clotting issues.
Myanmar: Rhesus Macaque

New Study Suggests COVID-19 Reinfection Unlikely

The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
Scroll Up